Loren Miller, MD
Enriched profileProfessor of Medicine, David Geffen School of Medicine at UCLA; Chief, Division of Adult Infectious Diseases, Harbor-UCLA Medical Center · University of California, Los Angeles
Loren Miller is Professor of Medicine, David Geffen School of Medicine at UCLA; Chief, Division of Adult Infectious Diseases, Harbor-UCLA Medical Center at University of California, Los Angeles. OpenAlex indexes 317 publications with 16,724 citations (h-index 65); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Loren Miller, MD, is Professor of Medicine, David Geffen School of Medicine at UCLA at University of California, Los Angeles (David Geffen School of Medicine). The public record shows 317 publications with 16,724 citations (h-index 65), centered on Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, Streptococcal Infections and Treatments. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 11 companies, 4 NIH-funded awards (2000–2022).
- Most recent indexed publication: 2026 · Infection control and hospital epidemiology
- Top research focus: Antimicrobial Resistance in Staphylococcus
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 142.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Sponsor: Synairgen Research Ltd.
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Industry payments
Updated 14 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Paratek Pharmaceuticals, Inc.Program year202512 payments
- Merck Sharp & Dohme LLCProgram year202511 payments
- Shionogi IncProgram year202517 payments
NIH funding
Updated 14 Oct 2026
4 NIH research awards on record, funded 2000–2022 per NIH RePORTER. The latest:
- Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2022$1,002,378U01AI116400 - Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2021$1,083,522U01AI116400 - Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2020$1,106,595U01AI116400
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Are high residual chlorhexidine skin concentrations associated with improved clinical outcomes? Lessons from the CLEAR trial.
Infection control and hospital epidemiology
Article2026 - Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
Clinical infectious diseases
Article2026 - A Double-blind Randomized Trial of Oral Chlorhexidine Gluconate for Treatment of Oral Staphylococcus aureus Colonization in Healthy Children.
Open forum infectious diseases
Clinical Trial2026 - Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in Los Angeles County.
Infection control and hospital epidemiology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/loren-miller-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/loren-miller-5043ab2b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
people.healthsciences.ucla.edu/institution/personnel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.healthsciences.ucla.edu ↗ - Other
people.ctsi.ucla.edu/institution/personnel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.ctsi.ucla.edu ↗ - Other
profiles.ucla.edu/loren.miller
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - ResearchGate
researchgate.net/profile/Loren-Miller-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
harborid.org/loren-miller
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - Other
harboruclaid.org/loren-g--miller.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harboruclaid.org ↗ - Other
health.usnews.com/doctors/loren-miller-410858
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Other
lundquist.org/loren-miller-md-mph
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Columbia University College of Physicians and Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - M.P.H.
University of California, Los Angeles
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - B.A.
Asian Studies, University of California, Berkeley
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗ - Residency
Internal Medicine, Harbor-UCLA Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - Fellowship
Infectious Diseases, UCLA Multicampus Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - Fellow
American College of Physicians (ACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →harborid.org ↗ - Fellow
Infectious Diseases Society of America (IDSA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →harborid.org ↗
Editorial & leadership roles
journal and society appointments- Chief
Division of Adult Infectious Diseases, Harbor-UCLA Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - Principal Investigator
NIAID U01 clinical trial (PROTECT Trial, community-associated skin infections / nursing home decolonization)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗
Awards & honors
honors on the public record- 2024 Top Ten Clinical Research Achievement Award
Clinical Research Forum, for the PROTECT Trial (nursing home infection prevention)
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →harborid.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →harborid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →harborid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →harborid.org ↗
Secondary affiliations
appointments beyond the home institution- Investigator
Health Services and Outcomes Research, Infectious Diseases, The Lundquist Institute for Biomedical Innovation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗ - Associate Site Director
UCLA Clinical and Translational Science Institute (CTSI) at The Lundquist Institute/Harbor-UCLA campus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗ - Director
Harbor-UCLA Infectious Diseases Clinical Outcomes Research Unit (ID-CORE)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗ - HS Clinical Professor
Medicine, UCLA School of Medicine (UCLA Profiles listing)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - Member
Antibacterial Resistance Leadership Group (ARLG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucla.edu ↗
Media & interviews
press, podcasts and appearances- "A conversation with Loren Miller, MD, MPH, professor and chief, Division of Infectious Diseases, Lundquist Institute at Harbor-UCLA"
Q&A feature, Journal of Clinical and Translational Science, Vol. 9, Issue 1 …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Zev Wainberg, MD
University of California, Los Angeles
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre